Results 121 to 130 of about 2,752 (194)

A cost-effectiveness analysis comparing single-inhaler extrafine beclomethasone/formoterol/glycopyrronium bromide against other SITTs in adult patients with uncontrolled asthma in England. [PDF]

Health Econ Rev
Vlachaki I, Donhauser S, Madoni A, van der Deijl M, Sharma Y, Tzelis D, Guerra I.   +6 more
europepmc   +1 more source

Editorial: Advancing NSCLC treatment: overcoming challenges in immune checkpoint inhibitor therapy. [PDF]

Front Pharmacol
Liu R, Meng Y, Rahouma M.
europepmc   +1 more source

Analysis of Current Status and Influencing Factors of Inhaler Treatment Adherence Among COPD Patients. [PDF]

Int J Chron Obstruct Pulmon Dis
Jin Z, Ba B, Zhang W, Yang Z, Wang X.
europepmc   +1 more source

Prospective, Open-Label, Observational, Multicenter, Single Arm, Post-Marketing Study in Asthmatic Patients for Evaluation of Safety and Effectiveness of Indacaterol/Mometasone DPI (PROMISING-SHIFT). [PDF]

Adv Respir Med
Karmakar S, Singh GV, Bhate AS, Barge V, Mehrotra B, Patel C, Sinha E, Bhagat S, Patil S, Barkate H.   +9 more
europepmc   +1 more source

To Study the Safety and Efficacy of Fixed Dose Combination of Indacaterolmaleate 110 µg + Glycopyrrinium 50 µg versus Tiotropium 9 µg + Formoterol 12 µg in Patients with Chronic Obstructive Airway Disease.

Ann Afr Med
Shabbir J, Masood I, Waseem SMA, Masood SY.   +3 more
europepmc   +1 more source

Evaluating digital adherence support in asthma: the ADITION non-interventional study. [PDF]

ERJ Open Res
Woehrle H, Driemert J, Jerrentrup L, Schiefer C, Bushart G, Schwab Sauerbeck I.   +5 more
europepmc   +1 more source

Virtual Screening of FDA-Approved Compounds: Exploring New Alternatives for HIV Treatment. [PDF]

ACS Omega
Martinez DP, Kremer FS.
europepmc   +1 more source

Interventions to reduce the impact of post-tuberculosis lung disease: a scoping review of the literature. [PDF]

BMC Pulm Med
Byrne AL, Günther G, Tadyanemhandu C, de Almeida CPB, Dewi IM, Mitnick CD, Koenig SP, Romanowski K, Wallis RS.   +8 more
europepmc   +1 more source

Current Smoking and Pharmacological Treatment Responses in Chronic Obstructive Pulmonary Disease: Not Clear-Cut. [PDF]

Am J Respir Crit Care Med
Bardsley S, Fagerås M, Marshall J, Martin N, Psallidas I, Singh D.   +5 more
europepmc   +1 more source

Pharmacologic Therapies for Preventing Chronic Obstructive Pulmonary Disease Exacerbations: A Comprehensive Review. [PDF]

Tuberc Respir Dis (Seoul)
Lee HW.
europepmc   +1 more source